More about Apollo Hospitals Enterprise Limited
Fundamentals for Apollo Hospitals Enterprise Limited
Regulatory Filings for Apollo Hospitals Enterprise Limited
From Cost Center to Strategic Core: The Top 10 Trends Transforming Finance in 2026
CFOs Seize the Tech Purse Strings: How 2026 Budgets Are Fueling the AI Transformation
From Agentic AI to Tokenized Assets: The Fintech Trends Reshaping Financial Services
Forex Focus: How a Weakening Indian Rupee Could Reshape Markets in Q1 2026
Fundamentals for Apollo Hospitals Enterprise Limited
Business Operations:
Sector: HealthcareIndustry: Medical Care Facilities
Apollo Hospitals Enterprise Limited, together with its subsidiaries, engages in the provision of healthcare services in India and internationally. It operates through Healthcare Services, Retail Health & Diagnostics, Digital Health & Pharmacy Distribution, and Others segments. The company's healthcare facilities comprise primary, secondary, and tertiary care, as well as specialty facilities. It offers services in cardiac sciences, orthopedics, oncology, neurosciences, emergency, robotic surgery, and transplants; and cardiology, neurology, gastroenterology, dermatology, ophthalmology, pediatric, endocrinology, gynecology, urology, nephrology, pulmonology, rheumatology, neurosurgery, radiology, plastic-surgery, neonatology, vascular-surgery, psychiatry, dentistry, ear, nose, and throat care, as well as genomic medicines. The company also provides other services, such as project consultancy, health insurance, medical colleges, medvarsity for e-learning, and research services. In addition, it operates pharmacies, primary care clinics, birthing centers, specialized birthing centers, dialysis centers, cradle and fertility centers, diabetes management centers, single specialty clinics, primary health centers and diagnostic chains, dental clinics, and daycare and home healthcare centers. Further, the company engages in the business of bio-banking of tissues. It serves through national retail healthcare centers and genomics institutes, as well as Apollo 24/7, a digital health mobile platform; and www.apollopharmacy.in, an online pharmacy. The company was incorporated in 1979 and is based in Chennai, India.
Revenue projections:
APOLLOHOSP is projected to experience a revenue decline compared to last year, a development that often leads to investor caution. The drop could negatively impact the company's bottom line, as lower revenues typically signal reduced profitability, prompting more conservative investment strategies.
Financial Ratios:
| currentRatio | 0.00000 |
|---|---|
| forwardPE | 45.70463 |
| debtToEquity | 83.60600 |
| earningsGrowth | 0.35000 |
| revenueGrowth | 0.17200 |
| grossMargins | 0.34257 |
| operatingMargins | 0.11519 |
| trailingEps | 125.66000 |
| forwardEps | 166.62425 |
APOLLOHOSP's elevated debt-to-equity ratio highlights its heavy reliance on debt. This high leverage increases the company's exposure to financial risk, making it more vulnerable to market fluctuations and economic downturns.
APOLLOHOSP's positive earnings and revenue growth indicate that the company is on track to expand its business. This growth suggests a strong financial outlook, with increasing profits and sales positioning APOLLOHOSP for continued success in the market.
APOLLOHOSP's forward EPS is higher than its trailing EPS, which signals that the company is expected to achieve greater profitability this financial year. This suggests improved earnings performance, indicating a positive outlook for APOLLOHOSP's financial growth.
Price projections:
Price projections for APOLLOHOSP have consistently been revised upward, indicating positive sentiment toward the company. This gradual adjustment reflects growing confidence in APOLLOHOSP's future potential and financial outlook among analysts.
Insider Transactions:
3 separate transactions to buy Apollo Hospitals Enterprise Limited were completed, while market price hovered around 6553.183268229167.There were no buy transactions throughout the period under consideration.APOLLOHOSP has seen more sells at current price levels, which could indicate a potential decline. If this trend continues, investors may expect the stock's price to drop further as more people exit their positions.
Recommendation changes over time:
APOLLOHOSP has received a favorable buy bias from analysts recently, positioning it as a solid investment opportunity. This sentiment may attract more investors, who view APOLLOHOSP as a stable option to park their money and potentially benefit from the company's continued growth and profitability.
DISCLAIMER: We provide information and our musings based on events, but nothing on this site can be considered professional advice of any kind.
If you have enjoyed reading, spread the word:
Good prospects:
Companies with the best and the worst fundamentals.
Latest Regulatory Filings for NSE500
Companies with the best and the worst technicals.
Understanding Divergent House Price Movements Worldwide
The 2026 Tariff Tipping Point: When Trade Policy Reaches the Consumer
From Caracas to Commodities: The Market Impact of U.S.–China Friction